{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:08:19Z","timestamp":1794978499310,"version":"4.9.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory scores are known to reflect the systemic inflammatory burden. Despite this, the association between the inflammatory score and the risk of all-cause and cardiovascular mortality in patients with metabolic syndrome (MetS) remains poorly understood. To address this gap in the literature, this study investigated this potential association between these two factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 3401 patients with MetS from the National Health and Nutrition Examination Survey (1999\u20132010) were enrolled. Survival status and cause of death were obtained by linking data from the National Death Index (NDI). The inflammatory score was calculated based on the sum of the Z-scores for white blood cell (WBC) count and C-reactive protein (CRP) at baseline. The patients were divided into inflammatory score quartiles. Cox proportional hazards regression was used to determine the association between inflammatory score and mortality. Restricted cubic splines (RCS) were used to explore the dose-response relationship between inflammatory score and mortality. Stratified analyses and interaction tests were conducted according to sex, age, body mass index (BMI), alcohol consumption, smoking status, hypertension, diabetes, and stroke status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After a mean follow-up of 145.9 months, 1039 all-cause deaths and 295 cardiovascular deaths were recorded. The results of multivariate Cox regression analysis showed that compared to the lowest quartile (Q1), patients in the highest quartile (Q4) had a 1.74-fold increased risk of all-cause mortality (Model 3: HR = 1.74, 95%CI 1.30\u20132.32,\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001) and a 1.87-fold increased risk of cardiovascular mortality (Model 3: HR = 1.87, 95%CI 1.12\u20133.13,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.020). There was a \u2018J\u2019-shaped nonlinear relationship between the inflammatory score and all-cause mortality (\n                      <jats:italic>P<\/jats:italic>\n                      for nonlinearity = 0.001), and a marginally significant \u2018J\u2019-shaped relationship with cardiovascular mortality (\n                      <jats:italic>P<\/jats:italic>\n                      for nonlinearity = 0.057). The threshold points of the inflammatory score for adverse outcomes were - 0.643 and - 0.621, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The inflammatory score is independently associated with increased all-cause and cardiovascular mortality in patients with MetS, and risk stratification of these patients using inflammatory scores may provide specific therapeutic strategies to improve their prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1410871","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:56:41Z","timestamp":1719795401000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Association of inflammatory score with all-cause and cardiovascular mortality in patients with metabolic syndrome: NHANES longitudinal cohort study"],"prefix":"10.3389","volume":"15","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The metabolic syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1029736","article-title":"Incidence and long-term specific mortality trends of metabolic syndrome in the United States","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003-2012","volume":"313","author":"Aguilar","year":"2015","journal-title":"Jama"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1152\/physiol.00012.2016","article-title":"Physiological aging: links among adipose tissue dysfunction, diabetes, and frailty","volume":"32","author":"Stout","year":"2017","journal-title":"Physiol (Bethesda)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2019.12.012","article-title":"Prevalence of metabolic syndrome in sub-Saharan Africa: A systematic review and meta-analysis","volume":"30","author":"Jaspers Faijer-Westerink","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140677.20606.0E","article-title":"Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults","volume":"110","author":"Malik","year":"2004","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2007.01781.x","article-title":"Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality\u2013results of prospective analysis for the Atherosclerosis Risk in Communities study","volume":"262","author":"Hong","year":"2007","journal-title":"J Intern Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.06.082","article-title":"Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions","volume":"46","author":"Koh","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000158483.13093.9D","article-title":"Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation","volume":"111","author":"Dandona","year":"2005","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.09.001","article-title":"Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome","volume":"195","author":"Kuller","year":"2007","journal-title":"Atherosclerosis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq103","article-title":"C-reactive protein and all-cause mortality\u2013the Copenhagen City Heart Study","volume":"31","author":"Zacho","year":"2010","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000132467.45278.59","article-title":"Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa160","article-title":"Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur Heart J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.09.016","article-title":"Association of ideal cardiovascular health metrics with serum uric acid, inflammation and atherogenic index of plasma: A population-based survey","volume":"284","author":"Mazidi","year":"2019","journal-title":"Atherosclerosis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2016.12.003","article-title":"Ideal cardiovascular health and inflammation in European adolescents: The HELENA study","volume":"27","author":"Gonz\u00e1lez-Gil","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12885-016-2115-6","article-title":"Inflammatory biomarker score and cancer: A population-based prospective cohort study","volume":"16","author":"Morrison","year":"2016","journal-title":"BMC cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23731","article-title":"The mediation effect of HDL-C: Non-HDL-C on the association between inflammatory score and recurrent coronary events","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"B22","doi-asserted-by":"publisher","first-page":"160096","DOI":"10.1038\/sdata.2016.96","article-title":"A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey","volume":"3","author":"Patel","year":"2016","journal-title":"Sci Data"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III)","volume":"285","year":"2001","journal-title":"Jama"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2000.71.5.743","article-title":"Smoking-attributable periodontitis in the United States: findings from NHANES III","volume":"71","author":"Tomar","year":"2000","journal-title":"J Periodontol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep4.1803","article-title":"Inverse association of telomere length with liver disease and mortality in the US population","volume":"6","author":"Rattan","year":"2022","journal-title":"Hepatol Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-024-02152-y","article-title":"Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study","volume":"23","author":"Liu","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B27","first-page":"1","article-title":"National health and nutrition examination survey: analytic guidelines, 1999-2010","author":"Johnson","year":"2013","journal-title":"Vital Health Stat 2"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0900","article-title":"C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study","volume":"58","author":"Bruno","year":"2009","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2021.09.022","article-title":"The relationship between C-Reactive protein and mortality in adults with diabetes: Influences of demographic characteristics, lifestyle behaviors, and medications","volume":"32","author":"Akinboboye","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-1353","article-title":"CRP, C-peptide, and risk of first-time cardiovascular events and mortality in early type 2 diabetes: A Danish cohort study","volume":"46","author":"Gedebjerg","year":"2023","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S427149","article-title":"An easy-to-use nomogram based on SII and SIRI to predict in-hospital mortality risk in elderly patients with acute myocardial infarction","volume":"16","author":"Chen","year":"2023","journal-title":"J Inflammation Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031128","article-title":"Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: A 20-year follow-up cohort study of 42,875 US adults","volume":"12","author":"Xia","year":"2023","journal-title":"J Clin Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.952953","article-title":"Association of the systemic immune-inflammation index with all-cause mortality in patients with arteriosclerotic cardiovascular disease","volume":"9","author":"He","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0383","article-title":"Nationwide trends in cardiac risk and mortality in patients with incident type 2 diabetes: a danish cohort study","author":"Gyldenkerne","year":"2021","journal-title":"Diabetes Care"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040967","article-title":"Inflammatory markers and the risk of coronary heart disease in men and women","volume":"351","author":"Pai","year":"2004","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.4.889","article-title":"C-reactive protein and incident cardiovascular events among men with diabetes","volume":"27","author":"Schulze","year":"2004","journal-title":"Diabetes Care"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004554","article-title":"Prognostic importance of C-reactive protein in high cardiovascular risk patients with type 2 diabetes mellitus: the Rio de Janeiro type 2 diabetes cohort study","volume":"5","author":"Cardoso","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0169","article-title":"The role of markers of low-grade inflammation for the early time course of glycemic control, glucose disappearance rate, and \u03b2-cell function in recently diagnosed type 1 and type 2 diabetes","volume":"38","author":"Weber","year":"2015","journal-title":"Diabetes Care"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-014-0124-9","article-title":"Low-grade inflammation, obesity, and diabetes","volume":"3","author":"Pereira","year":"2014","journal-title":"Curr Obes Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7395627","article-title":"NALP3-inflammasome-related gene polymorphisms in patients with prehypertension and coronary atherosclerosis","volume":"2016","author":"Zhao","year":"2016","journal-title":"BioMed Res Int"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.479","article-title":"White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese\u2013results from the NIPPON DATA90","volume":"71","author":"Tamakoshi","year":"2007","journal-title":"Circ J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.04.029","article-title":"The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: population-based cohort study","volume":"192","author":"Shankar","year":"2007","journal-title":"Atherosclerosis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12889-024-17885-4","article-title":"Ideal cardiovascular health and risk of death in a large Swedish cohort","volume":"24","author":"Ding","year":"2024","journal-title":"BMC Public Health"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000060923.07573.F2","article-title":"Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism)","volume":"107","author":"Steinberger","year":"2003","journal-title":"Circulation"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2525","article-title":"Normal-weight central obesity: implications for total and cardiovascular mortality","volume":"163","author":"Sahakyan","year":"2015","journal-title":"Ann Intern Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: A scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"Jama"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12003","article-title":"Obesity and C-reactive protein in various populations: a systematic review and meta-analysis","volume":"14","author":"Choi","year":"2013","journal-title":"Obes Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu059","article-title":"C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians","volume":"35","author":"Sung","year":"2014","journal-title":"Eur Heart J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23849","article-title":"To handle the inflation of odds ratios in a retrospective study with a profile penalized log-likelihood approach","volume":"35","author":"Tzeng","year":"2021","journal-title":"J Clin Lab Anal"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1410871\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:56:48Z","timestamp":1719795408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1410871\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2024.1410871"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1410871","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1410871.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1410871.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1410871.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1410871.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1410871.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2024.1410871.s006","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,1]]},"article-number":"1410871"}}